Cairn Investment Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.47M | Buy |
22,283
+160
| +0.7% | +$17.7K | 1.29% | 28 |
|
2025
Q1 | $2.48M | Sell |
22,123
-156
| -0.7% | -$17.5K | 1.4% | 27 |
|
2024
Q4 | $2.06M | Sell |
22,279
-65
| -0.3% | -$6K | 1.21% | 29 |
|
2024
Q3 | $1.87M | Sell |
22,344
-479
| -2% | -$40.2K | 1.04% | 32 |
|
2024
Q2 | $1.57M | Sell |
22,823
-1,450
| -6% | -$99.5K | 0.91% | 34 |
|
2024
Q1 | $1.78M | Sell |
24,273
-200
| -0.8% | -$14.7K | 1.02% | 32 |
|
2023
Q4 | $1.98M | Buy |
24,473
+1,355
| +6% | +$110K | 1.24% | 25 |
|
2023
Q3 | $1.73M | Buy |
23,118
+3,485
| +18% | +$261K | 1.15% | 26 |
|
2023
Q2 | $1.51M | Buy |
19,633
+740
| +4% | +$57K | 0.98% | 30 |
|
2023
Q1 | $1.57M | Buy |
18,893
+20
| +0.1% | +$1.66K | 1.09% | 26 |
|
2022
Q4 | $1.62M | Buy |
18,873
+761
| +4% | +$65.3K | 1.21% | 28 |
|
2022
Q3 | $1.12M | Sell |
18,112
-3,340
| -16% | -$206K | 0.9% | 37 |
|
2022
Q2 | $1.33M | Buy |
21,452
+1,365
| +7% | +$84.4K | 1.03% | 35 |
|
2022
Q1 | $1.54M | Buy |
20,087
+1,125
| +6% | +$86.1K | 0.97% | 37 |
|
2021
Q4 | $1.38M | Sell |
18,962
-1,385
| -7% | -$101K | 0.95% | 35 |
|
2021
Q3 | $1.42M | Buy |
20,347
+2,475
| +14% | +$173K | 1.05% | 32 |
|
2021
Q2 | $1.23M | Buy |
17,872
+435
| +2% | +$29.9K | 0.9% | 37 |
|
2021
Q1 | $1.13M | Sell |
17,437
-1,595
| -8% | -$103K | 0.94% | 37 |
|
2020
Q4 | $1.11M | Sell |
19,032
-85
| -0.4% | -$4.95K | 1.05% | 35 |
|
2020
Q3 | $1.21M | Buy |
19,117
+625
| +3% | +$39.5K | 1.28% | 32 |
|
2020
Q2 | $1.42M | Sell |
18,492
-415
| -2% | -$31.9K | 1.73% | 23 |
|
2020
Q1 | $1.41M | Buy |
18,907
+10,415
| +123% | +$778K | 2.1% | 16 |
|
2019
Q4 | $551K | Buy |
+8,492
| New | +$551K | 0.55% | 62 |
|